HomeSUVENPHAR • NSE
add
Suven Pharmaceuticals Ltd
Previous close
₹1,274.45
Day range
₹1,274.45 - ₹1,303.15
Year range
₹598.00 - ₹1,353.95
Market cap
327.03B INR
Avg Volume
250.06K
P/E ratio
134.71
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.58B | 11.54% |
Operating expense | 1.19B | 104.14% |
Net income | 822.10M | 3.33% |
Net profit margin | 31.90 | -7.38% |
Earnings per share | — | — |
EBITDA | 1.02B | 4.18% |
Effective tax rate | 17.61% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.56B | -8.10% |
Total assets | 25.06B | 18.20% |
Total liabilities | 4.77B | 158.80% |
Total equity | 20.28B | — |
Shares outstanding | 254.52M | — |
Price to book | 16.40 | — |
Return on assets | — | — |
Return on capital | 10.40% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 822.10M | 3.33% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1989
Website
Employees
1,052
